The majority of studies on GIP to date have focused on its insulinotropic actions and β-cell functions, and long-term administration of DPP-IV resistant GIP analogues has been shown to markedly improve glucose tolerance in normal and diabetic rats, as well as in high fat (HF) fed mice [10]–[12]. This evidence concerns the gene GIP and hydrops fetalis.